Companies › SER

SERINA THERAPEUTICS INC (SER)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001708599 · EDGAR filings · Updated 2026-07-23

SERINA THERAPEUTICS INC (SER) has reported institutional ownership of 11.8%, with 24 institutional managers holding positions valued at $2.81M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (5)

• 2026-07-23 — Insider transaction reported (Form 4)
• 2026-07-23 — Initial insider ownership filed (Form 3)
• 2026-07-23 — Current report (8-K) filed
• 2026-07-22 — Current report (8-K) filed
• 2026-07-22 — SCHEDULE 13D/A filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-09 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, SERINA THERAPEUTICS INC has 24 institutional holders and institutional ownership of 11.8%.

Insider activity

Insiders reported 83 transactions (0 buys, 41 sells) across 2 reporting insiders, with a net reported value of −$1.12M.

Data flags from SEC filings

Related companies

Telomir Pharmaceuticals Inc (TELO) · Celularity Inc (CELU) · Lantern Pharma Inc (LTRN) · ONCOLYTICS BIOTECH INC COM NEW (ONCY) · Bolt Biotherapeutics Inc (BOLT) · BIOATLA INC (BCAB)